XML 63 R35.htm IDEA: XBRL DOCUMENT v3.25.4
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense

Stock‑based compensation expense is included in the consolidated statements of income and comprehensive income as follows:

 

 

 

Year Ended December 31,

 

(In thousands)

 

2025

 

 

2024

 

 

2023

 

Selling, general and administrative

 

$

8,930

 

 

$

6,040

 

 

$

4,645

 

Research and development

 

 

522

 

 

 

334

 

 

 

1,192

 

Total

 

$

9,452

 

 

$

6,374

 

 

$

5,837

 

Schedule of Stock-based Compensation Expense Included in the Consolidated Statements of Income and Comprehensive Income by Award Type

Stock‑based compensation expense included in the consolidated statements of income and comprehensive income by award type is as follows:

 

 

 

Year Ended December 31,

 

(In thousands)

 

2025

 

 

2024

 

 

2023

 

Stock options

 

$

3,995

 

 

$

2,738

 

 

$

1,980

 

RSUs

 

 

5,041

 

 

 

3,348

 

 

 

3,663

 

RSAs

 

 

76

 

 

 

123

 

 

 

168

 

ESPP

 

 

340

 

 

 

165

 

 

 

26

 

Total stock-based compensation expense

 

$

9,452

 

 

$

6,374

 

 

$

5,837

 

Schedule of Unrecognized Stock-based Compensation Cost

As of December 31, 2025, the unrecognized stock-based compensation cost and the estimated weighted-average amortization period were as follows:

 

(In thousands)

 

Unrecognized Compensation Cost

 

 

Weighted-Average Amortization Period (Years)

 

Stock options

 

$

9,140

 

 

 

2.6

 

RSUs

 

 

13,354

 

 

 

2.8

 

RSAs

 

 

22

 

 

 

0.7

 

ESPP

 

 

225

 

 

 

0.4

 

Total unrecognized compensation expense

 

$

22,741

 

 

 

 

 

Summary of Equity Award Activity and Related Information

The following table summarizes equity award activity under the 2012 Plan and prior plans and related information:

 

(In thousands, except per share data)

 

Number of outstanding options

 

 

Weighted-Average Exercise Price of Outstanding Options

 

 

Number of outstanding RSUs

 

 

Weighted-Average Fair Value per Share at Grant

 

 

Number of outstanding RSAs

 

 

Weighted-Average Fair Value per Share at Grant

 

Balance as of December 31, 2024

 

 

2,067

 

 

$

15.23

 

 

 

598

 

 

$

15.00

 

 

 

7

 

 

$

15.50

 

Granted

 

 

870

 

 

$

18.00

 

 

 

662

 

 

$

18.18

 

 

 

 

 

$

 

Exercised

 

 

(85

)

 

$

15.09

 

 

 

 

 

 

 

 

 

 

 

 

 

Released RSUs and RSAs

 

 

 

 

 

 

 

 

(300

)

 

$

15.10

 

 

 

(5

)

 

$

15.78

 

Forfeited

 

 

(17

)

 

$

15.87

 

 

 

(36

)

 

$

15.70

 

 

 

 

 

$

 

Expired

 

 

(1

)

 

$

14.11

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of December 31, 2025

 

 

2,834

 

 

$

16.08

 

 

 

924

 

 

$

17.22

 

 

 

2

 

 

$

14.77

 

Vested and expected to vest
   as of December 31, 2025

 

 

2,834

 

 

$

16.08

 

 

 

924

 

 

$

17.22

 

 

 

 

 

 

 

Summary of Weighted-Average Assumptions used to Calculate Estimated Value of Stock Options

Black-Scholes-Merton weighted-average assumptions used in calculating the estimated value of stock options granted by Innoviva on the dates of grant were as follows:

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

 

2023

 

Risk-free interest rate

 

 

4.2

%

 

 

4.2

%

 

 

4.0

%

Expected term (in years)

 

 

6.07

 

 

 

6.10

 

 

 

6.09

 

Volatility

 

 

34.5

%

 

 

35.5

%

 

 

37.8

%

Dividend yield

 

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

 

 

 

 

 

 

 

 

 

Weighted-average estimated fair value of stock options granted

 

$

7.48

 

 

$

8.17

 

 

$

5.57